Exercise training for patients with chest pain and no blocked arteries
Official title: Ischemia With No Obstruction of Coronary Arteries: Underlying Mechanisms and the Impact of Exercise Training (EXINOCA)
Run by Bispebjerg Hospital · NCT06529848 · Data updated 2026-11-12
This study tests if regular aerobic exercise can help people with chest pain but no blocked arteries feel better by improving blood flow in their heart and other organs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Bispebjerg Hospital Academic / other |
| Locations | 2 sites (Copenhagen and 1 other locations) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | October 30, 2027 |
| Study ends | May 15, 2028 |
| Registry record updated | February 21, 2025 |
| Trial ID | NCT06529848 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with coronary microvascular dysfunction and no obstructive coronary artery disease.
✕Probably not a fit
Patients with heart failure, uncontrolled hypertension, or those unable to exercise will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the causes of chest pain in patients who have no signs of coronary artery blockage, focusing on coronary microvascular dysfunction. It aims to determine whether regular aerobic exercise can improve microvascular function in the heart and other organs, potentially alleviating symptoms. The study is a randomized controlled trial involving 100 patients, who will be assigned to either an exercise training group or a control group. The primary outcome measured will be coronary microvascular function, with secondary outcomes including symptom relief and microvascular function in other tissues.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive treatment option for patients suffering from chest pain due to microvascular dysfunction.
How similar studies have gone: While the specific approach of this study is novel, there is existing evidence suggesting that exercise can improve vascular function in other contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Coronary microvascular dysfunction, defined as myocardial bloodflow reserve (MBFR) \< 2.5 or hyperemic myocar-dial blood flow (hMBF)\<2.3 ml/g/min using \[15O\]H2O-PET * No obstructive coronary artery disease Exclusion Criteria: * Females of childbearing potential (defined as a premeno-pausal female capable of becoming pregnant). The female patient must either be postmenopausal, defined as amen-orrhea for at least 1 year, or surgically sterile * Heart failure, defined as left ventricular ejection fraction of less than 40% * Uncontrolled hypertension defined as blood pressure above target 140/90 for all * Co-morbidity resulting in \<1 year expected survival * Considered by the investigator, for any reason, to be an un-suitable candidate for the study. * Unable or unwilling to exercise, e.g. due to arthritis or in-jury\* * Already are regularly physically active and/or have a maxi-mal oxygen uptake \>45 ml/kg/min
Where it's running
-
Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57
Frederiksberg, Denmark Recruiting -
Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57, Frederiksberg, Denmark, 2000
Copenhagen, Denmark Not yet recruiting
Study contacts
- Principal investigator: Eva Prescott, MD, DMSc — University of Copenhagen
- Study coordinator: Eva Prescott, MD, DMSc
- Email: Eva.Irene.Bossano.Prescott@regionh.dk
- Phone: 004522572614
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Qishenyiqi Dripping Pill for treating Coronary Microvascular Disease
This study is testing if Qishenyiqi dripping pills can help people with microvascular angina feel better and improve their heart health compared to a placebo.
-
Observing coronary microvascular disease in patients
This study looks at patients with coronary microvascular disease to see how the condition develops and affects their quality of life and heart health.
-
Improving heart blood flow and angina in women using an SGLT2 pill (STRONG)
This trial will test whether taking the SGLT2 pill Brezavvy for 12 weeks can improve coronary microvascular blood flow and reduce angina symptoms in women with non-obstructive coronary artery disease.
-
Registry collecting data on microvascular dysfunction and coronary spasm
This study is collecting information from patients with microvascular dysfunction and coronary spasm to better understand their experiences and improve their care.
-
Understanding how heart conditions affect tolerance to rapid heart rates
This study is testing how well people with heart conditions, especially those with coronary artery disease, can handle fast heart rates and whether treating their condition with stents can help them tolerate it better.
-
Using fundus imaging to identify coronary microvascular disease
This study is testing if special eye imaging can help find heart problems related to small blood vessels in people who have normal coronary arteries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.